Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer

Cancer

Volumn 121, Issue 13, 2015, Pages 2271-2280

  Kinugasa, Hideaki ^a   Nouso, Kazuhiro ^a   Miyahara, Koji ^a   Morimoto, Yuki ^a   Dohi, Chihiro ^a   Tsutsumi, Koichiro ^a   Kato, Hironari ^a   Matsubara, Takehiro ^b   Okada, Hiroyuki ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

circulating DNA; circulating tumor DNA (ctDNA); digital polymerase chain reaction; K ras; liquid biopsy; pancreatic cancer

Indexed keywords

ARGININE; ASPARTIC ACID; CELL FREE CIRCULATING TUMOR DNA; DNA; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; GLYCINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CODON; CONTROLLED STUDY; DROPLET DIGITAL POLYMERASE CHAIN REACTION; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONCOGENE K RAS; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS SURGERY; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; SURVIVAL RATE; GENETICS; MIDDLE AGED; MUTATION; ONCOGENE RAS; PANCREAS TUMOR; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS;

EID: 84931061208     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29364     Document Type: Article

References (33)

1. Barbacid M,. ras genes. Annu Rev Biochem. 1987; 56: 779-827.
2. Bos JL,. ras oncogenes in human cancer: a review. Cancer Res. 1989; 49: 4682-4689.
3. Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra A,. Pancreatic carcinogenesis. Pancreatology. 2008; 8: 110-125.
4. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M,. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988; 53: 549-554.
5. Hruban RH, Goggins M, Parsons J, Kern SE,. Progression model for pancreatic cancer. Clin Cancer Res. 2000; 6: 2969-2972.
6. Ogura T, Yamao K, Hara K, et al., Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer. J Gastroenterol. 2013; 48: 640-646.
7. Fuccio L, Hassan C, Laterza L, et al., The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc. 2013; 78: 596-608.
8. Tada M, Omata M, Ohto M,. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology. 1991; 100: 233-238.
9. Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ,. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc. 2012; 75: 319-331.
10. Harewood GC, Wiersema MJ,. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol. 2002; 97: 1386-1391.
11. Gormally E, Caboux E, Vineis P, Hainaut P,. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007; 635: 105-117.
12. Murtaza M, Dawson SJ, Tsui DW, et al., Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013; 497: 108-112.
13. Dawson SJ, Tsui DW, Murtaza M, et al., Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013; 368: 1199-1201.
14. Gevensleben H, Garcia-Murillas I, Graeser MK, et al., Noninvasive detection of HER2 amplification with plasma DNA digital PCR. Clin Cancer Res. 2013; 19: 3276-3284.
15. Oka T, Matsunaga H, Tokunaga K, Mitsunaga S, Juji T, Yamane A,. A simple method for detecting single base substitutions and its application to HLA-DPB1 typing. Nucleic Acids Res. 1994; 22: 1541-1547.
16. Otsuki M,. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems. J Gastroenterol. 2003; 38: 315-326.
17. Vogelstein B, Kinzler KW,. Digital PCR. Proc Natl Acad Sci U S A. 1999; 96: 9236-9241.
18. Grunewald K, Lyons J, Frohlich A, et al., High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer. 1989; 43: 1037-1041.
19. Hindson BJ, Ness KD, Masquelier DA, et al., High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011; 83: 8604-8610.
20. Span M, Moerkerk PT, De Goeij AF, Arends JW,. A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int J Cancer. 1996; 69: 241-245.
21. Andreyev HJ, Norman AR, Cunningham D, et al., Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer. 2001; 85: 692-696.
22. Keohavong P, DeMichele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM,. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin Cancer Res. 1996; 2: 411-418.
23. John J, Frech M, Wittinghofer A,. Biochemical properties of Ha-ras encoded p21 mutants and mechanism of the autophosphorylation reaction. J Biol Chem. 1988; 263: 11792-11799.
24. Krengel U, Schlichting I, Scherer A, et al., Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell. 1990; 62: 539-548.
25. Kaplan PL, Ozanne B,. Cellular responsiveness to growth factors correlates with a cell's ability to express the transformed phenotype. Cell. 1983; 33: 931-938.
26. Al-Mulla F, MacKenzie EM,. Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations. J Pathol. 2001; 195: 549-556.
27. Meacham CE, Morrison SJ,. Tumour heterogeneity and cancer cell plasticity. Nature. 2013; 501: 328-337.
28. Bettegowda C, Sausen M, Leary RJ, et al., Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014; 6: 224ra24.
29. Rhim AD, Mirek ET, Aiello NM, et al., EMT and dissemination precede pancreatic tumor formation. Cell. 2012; 148: 349-361.
30. Rhim AD, Thege FI, Santana SM, et al., Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology. 2014; 146: 647-651.
31. Nelson MR, Marnellos G, Kammerer S, et al., Large-scale validation of single nucleotide polymorphisms in gene regions. Genome Res. 2004; 14: 1664-1668.
32. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K,. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 1995; 4: 357-362.
33. Taly V, Pekin D, Benhaim L, et al., Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin Chem. 2013; 59: 1722-1731.